MedPath
NMPA Approval

Recombinant Human Follitropin for Injection

国药准字S20150007

May 6, 2020

Drug Information

注射用重组人促卵泡激素

金赛恒

注射剂

5.5μg(75IU)/瓶

生物制品

May 6, 2020

Company Information

Applicant Company

长春高新开发区天河街72号

Manufacturing Company

长春市高新技术产业开发区越达路1718号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人促卵泡激素 - NMPA 批准文号 | MedPath